# Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD

> **NCT00259012** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 67 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** pantoprazole sodium enteric-coated spheroid suspension

## Key facts

- **NCT ID:** NCT00259012
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2010-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259012, "Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00259012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*